Back to Search Start Over

Neoadjuvant mFOLFIRINOX vs mFOLFIRINOX Plus Radiotherapy in Patients With Borderline Resectable Pancreatic Cancer-The A021501 Trial-Reply

Authors :
Matthew H. G. Katz
Joseph M. Herman
Eileen M. O’Reilly
Source :
JAMA oncology.
Publication Year :
2022

Subjects

Subjects :
Cancer Research
Oncology

Details

ISSN :
23742445
Database :
OpenAIRE
Journal :
JAMA oncology
Accession number :
edsair.doi.dedup.....0cca5e21d5822c042e4ac995f2230fff

Tools

Authors Abstract Subjects Details